STOCK TITAN
  1. Home
  2. Sec-filings
  3. ALOT
  4. [8-K] AstroNova, Inc. Reports Material Event

AstroNova (NASDAQ: ALOT) gains key HSR milestone for Arcline-backed merger

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

AstroNova, Inc. reported that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for its pending merger with Orion Merger Parent, Inc. and Orion MergerCo X, Inc., affiliates of investment funds managed by Arcline Investment Management LP, expired at 11:59 p.m. Eastern Time on July 31, 2026. This expiration satisfies the Merger Agreement condition related to HSR Act review.

The transaction, entered into on June 16, 2026, would merge Orion MergerCo X, Inc. with and into AstroNova, with AstroNova continuing as the surviving corporation and becoming a wholly owned subsidiary of Orion Merger Parent. Completion of the merger remains subject to other conditions in the Merger Agreement, including approval of the Merger Agreement by AstroNova shareholders at a special meeting described in a definitive proxy statement filed on July 31, 2026.

The company notes that statements about the proposed merger, including expected timing and satisfaction of closing conditions, are forward-looking and subject to risks such as failure to obtain shareholder approval, potential governmental challenges or conditions, disruption to business operations, possible termination of the Merger Agreement, and potential merger-related litigation.

Positive

  • Expiration of the HSR Act waiting period on July 31, 2026 satisfies a key antitrust-related condition to closing the proposed merger with Arcline-affiliated entities.

Negative

  • None.

Insights

Analyzing...

Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
HSR waiting period expiration date July 31, 2026 Expiration of HSR Act waiting period satisfying the related merger condition
HSR expiration time 11:59 p.m. Eastern Time Time on July 31, 2026 when the HSR Act waiting period expired
Merger Agreement date June 16, 2026 Date AstroNova entered into the Agreement and Plan of Merger
Proxy statement filing date July 31, 2026 Date the definitive proxy statement for the special meeting was filed with the SEC
Hart-Scott-Rodino Antitrust Improvements Act of 1976 regulatory
"the waiting period applicable under the Hart-Scott-Rodino Antitrust Improvements Act of 1976"
definitive proxy statement regulatory
"including the definitive proxy statement filed with the SEC on July 31, 2026"
A Definitive Proxy Statement is a detailed document that a company sends to its shareholders before a big meeting, like voting on important decisions. It explains what's being voted on and gives important information so shareholders can make informed choices. It matters because it helps shareholders understand and participate in key company decisions.
Special Meeting regulatory
"the special meeting of the Company’s shareholders to be held to consider and vote"
A special meeting is a shareholder gathering called outside the regular annual meeting to decide on urgent or specific corporate matters, such as mergers, major asset sales, changes to the board, or shareholder proposals. It matters to investors because decisions made there can quickly alter a company’s strategy, ownership or value—like a sudden boardroom decision that changes the game—so shareholders may need to vote, adjust holdings, or reassess risk based on the outcome.
forward-looking statements regulatory
"contains “forward-looking statements” within the meaning of the federal securities laws"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
proxy solicitation regulatory
"participants in the solicitation of proxies from the Company’s shareholders in connection with the Merger"
Proxy solicitation is the process of asking shareholders for permission to vote their shares on corporate matters, usually by sending voting forms or requests by mail, email or phone. Investors should watch proxy solicitations because they signal attempts to change control, influence board elections or approve big deals — like neighbors organizing votes on a shared building project — and the outcome can materially affect a company’s strategy and stock value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →

FAQ

What did AstroNova (ALOT) disclose about the HSR Act review for its merger?
AstroNova disclosed that the HSR Act waiting period for its proposed merger with Arcline-affiliated Orion Merger Parent and Orion MergerCo X expired at 11:59 p.m. Eastern Time on July 31, 2026, satisfying the Merger Agreement condition tied to U.S. antitrust waiting periods.

What is the structure of the proposed AstroNova (ALOT) merger?
Under the Merger Agreement, Orion MergerCo X, Inc. will merge with and into AstroNova, with AstroNova surviving and becoming a wholly owned subsidiary of Orion Merger Parent, Inc., an entity affiliated with investment funds managed by Arcline Investment Management LP.

What conditions still need to be met before the AstroNova (ALOT) merger can close?
Despite the HSR waiting period expiring, closing the merger still depends on satisfaction or waiver of other Merger Agreement conditions, including shareholder approval of the Merger Agreement at a special meeting and the absence of terminating events or circumstances.

When was the AstroNova (ALOT) Merger Agreement signed and proxy filed?
AstroNova entered into the Merger Agreement on June 16, 2026. A definitive proxy statement related to the special meeting of shareholders to vote on the Merger Agreement was filed with the SEC on July 31, 2026 and provided to shareholders.

What risks to completion of the AstroNova (ALOT) merger are highlighted?
AstroNova highlights risks including failure to obtain shareholder approval, potential governmental challenges or conditions on the merger, failure to satisfy other closing conditions, possible termination of the Merger Agreement, business disruption, and potential merger-related litigation impacting operations or results.

Where can AstroNova (ALOT) investors find detailed information about the merger?
Investors can review the definitive proxy statement filed on July 31, 2026, and other related materials available free of charge on the SEC’s website and AstroNova’s investor relations site, which describe the merger terms, conditions, and participants in the proxy solicitation.
false 0000008146 0000008146 2026-07-31 2026-07-31
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of report (Date of earliest event reported): July 31, 2026

 

 

ASTRONOVA, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Rhode Island   0-13200   05-0318215
(State or other jurisdiction   (Commission   (I.R.S. Employer
of incorporation)   File Number)   Identification No.)

600 East Greenwich Avenue

West Warwick, RI 02893

(Address of principal executive offices) (Zip Code)

(401) 828-4000

Registrant’s telephone number, including area code

Not applicable

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

  ☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

  ☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

  ☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

  ☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

  

Trading

Symbol(s)

  

Name of Each Exchange

on which Registered

Common Stock, $0.05 Par Value   ALOT   Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 

Item 8.01

Other Events.

As previously disclosed, on June 16, 2026, AstroNova, Inc., a Rhode Island corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Orion Merger Parent, Inc., a Delaware corporation (“Parent”), and Orion MergerCo X, Inc., a Rhode Island corporation and a wholly owned subsidiary of Parent (“Merger Sub”), pursuant to which and upon the terms and subject to the conditions thereof, Merger Sub will be merged with and into the Company (the “Merger”), with the Company continuing as the surviving corporation in the Merger and becoming a wholly owned subsidiary of Parent. Parent and Merger Sub are affiliates of investment funds managed by Arcline Investment Management LP (“Arcline”).

The completion of the Merger is conditioned upon, among other things, the expiration or termination of the waiting period (and any extensions thereof) applicable to the consummation of the transactions contemplated by the Merger Agreement under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”). The HSR Act waiting period expired at 11:59 p.m. Eastern Time on July 31, 2026, and accordingly the condition to the completion of the Merger relating to the expiration or termination of the HSR Act waiting period has been satisfied. The completion of the Merger remains subject to the satisfaction or waiver of the other conditions set forth in the Merger Agreement, including the approval of the Merger Agreement by the Company’s shareholders at the Special Meeting (as defined below).

Forward-Looking Statements

This Current Report on Form 8-K contains “forward-looking statements” within the meaning of the federal securities laws, including statements regarding the proposed Merger, the expected timing of the completion of the Merger and the satisfaction of the conditions to the completion of the Merger. These statements are based on the Company’s current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially, including: the failure to obtain the approval of the Company’s shareholders; the possibility that a governmental entity may nonetheless seek to challenge or impose conditions on the Merger; the failure to satisfy other conditions to the completion of the Merger; the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger Agreement; the effect of the announcement or pendency of the Merger on the Company’s business relationships, operating results and business generally; risks that the Merger disrupts current plans and operations; potential litigation relating to the Merger; and the other risks described in the Company’s filings with the SEC, including the Proxy Statement and the Company’s most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q. Except as required by law, the Company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

Additional Information and Where to Find It

In connection with the proposed Merger, the Company has filed and will file relevant materials with the U.S. Securities and Exchange Commission (“SEC”), including the definitive proxy statement (the “Proxy Statement”) filed with the SEC on July 31, 2026, relating to the special meeting of the Company’s shareholders to be held to consider and vote upon the adoption of the Merger Agreement (the “Special Meeting”). The Company has provided the Proxy Statement to its shareholders. This Current Report on Form 8-K is not a substitute for the Proxy Statement or any other document that the Company has filed or may file with the SEC in connection with the proposed Merger. THE COMPANY URGES YOU TO READ THE PROXY STATEMENT AND OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY, ARCLINE, THE MERGER AND

RELATED MATTERS. You are able to obtain a free copy of the Proxy Statement and other related documents (when available) filed by the Company with the SEC at the website maintained by the SEC at https://www.sec.gov. You are also able to obtain a free copy of the Proxy Statement and other documents (when available) filed by the Company with the SEC by accessing the investor relations section of the Company’s website at https://investors.astronovainc.com/investors/financial-reports/sec-filings/default.aspx or by contacting the Company’s investor relations using the form found on the Company’s website at https://investors.astronovainc.com/investors/resources/contact-ir/default.aspx.

Participants in the Solicitation

The Company and its directors and executive officers, and certain other members of the Company’s management and employees, may be deemed to be participants in the solicitation of proxies from the Company’s shareholders in connection with the Merger.

Information regarding the Company’s directors and executive officers, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth (i) in Amendment No. 1 to the Company’s Annual Report on Form 10-K, which was filed with the SEC on June 1, 2026, including under the headings “Part III—Directors, Executive Officers and Corporate Governance ,” “Part III—Executive Compensation,” “Part III— Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters,” and “Part III— Certain Relationships, Related Transactions and Director Independence,” which is available at https://www.sec.gov/ix?doc=/Archives/edgar/data/0000008146/000119312526251606/d154617d10ka.htm, (ii) in the Proxy Statement, including under the headings “Proposal No. 1—The Merger—Interests of Directors and Executive Officers in the Merger,” “Proposal No.2—Advisory (non-binding) Vote on Merger-related Executive Compensation,” and “Certain Beneficial Owners of Common Stock—Security Ownership of Directors and Officers” which is available at https://www.sec.gov/Archives/edgar/data/8146/000119312526326441/d140981ddefm14a.htm, and (iii) to the extent holdings of the Company’s securities by its directors or executive officers change after the date hereof, such changes will be reflected on Statements of Changes in Beneficial Ownership on Form 4 filed with the SEC, which are available at EDGAR Search Results https://www.sec.gov/edgar/browse/?CIK=0000008146&owner=only.

Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, are or will be contained in the Proxy Statement and other relevant materials to be filed with the SEC when they become available. You may obtain free copies of these documents through the website maintained by the SEC at https://www.sec.gov.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

        ASTRONOVA, INC.
Dated: August 5, 2026   By:  

/s/ Thomas D. DeByle

      Thomas D. DeByle
      Vice President, Chief Financial Officer and Treasurer

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

Other Documents